These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17391433)

  • 61. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Engineering novel Lec1 glycosylation mutants in CHO-DUKX cells: molecular insights and effector modulation of N-acetylglucosaminyltransferase I.
    Zhong X; Cooley C; Seth N; Juo ZS; Presman E; Resendes N; Kumar R; Allen M; Mosyak L; Stahl M; Somers W; Kriz R
    Biotechnol Bioeng; 2012 Jul; 109(7):1723-34. PubMed ID: 22252477
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation.
    Gaudry JP; Arod C; Sauvage C; Busso S; Dupraz P; Pankiewicz R; Antonsson B
    Protein Expr Purif; 2008 Mar; 58(1):94-102. PubMed ID: 18082421
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.
    Lee JH; Yeo J; Park HS; Sung G; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Protein Expr Purif; 2013 Jan; 87(1):17-26. PubMed ID: 23009882
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen.
    Cabrera G; Cremata JA; Valdés R; García R; González Y; Montesino R; Gómez H; González M
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):67-76. PubMed ID: 15049731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Humanizing glycosylation pathways in eukaryotic expression systems.
    Khan AH; Bayat H; Rajabibazl M; Sabri S; Rahimpour A
    World J Microbiol Biotechnol; 2017 Jan; 33(1):4. PubMed ID: 27837408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of shear stress on intrinsic CHO culture state and glycosylation of recombinant tissue-type plasminogen activator protein.
    Senger RS; Karim MN
    Biotechnol Prog; 2003; 19(4):1199-209. PubMed ID: 12892482
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of glycosylation pattern on the molecular properties of monoclonal antibodies.
    Zheng K; Yarmarkovich M; Bantog C; Bayer R; Patapoff TW
    MAbs; 2014; 6(3):649-58. PubMed ID: 24662970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A framework for real-time glycosylation monitoring (RT-GM) in mammalian cell culture.
    Tharmalingam T; Wu CH; Callahan S; T Goudar C
    Biotechnol Bioeng; 2015 Jun; 112(6):1146-54. PubMed ID: 25545171
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emerging technologies for making glycan-defined glycoproteins.
    Wang LX; Lomino JV
    ACS Chem Biol; 2012 Jan; 7(1):110-22. PubMed ID: 22141574
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Customized protein glycosylation to improve biopharmaceutical function and targeting.
    Van Landuyt L; Lonigro C; Meuris L; Callewaert N
    Curr Opin Biotechnol; 2019 Dec; 60():17-28. PubMed ID: 30554064
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Controlled glycosylation of therapeutic antibodies in plants.
    Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
    Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.
    Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
    J Immunol Methods; 2005 Nov; 306(1-2):93-103. PubMed ID: 16236307
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactories.
    Gugliotta A; Ceaglio N; Raud B; Forno G; Mauro L; Kratje R; Oggero M
    Eur J Pharm Biopharm; 2017 Mar; 112():119-131. PubMed ID: 27867113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation.
    Ha S; Ou Y; Vlasak J; Li Y; Wang S; Vo K; Du Y; Mach A; Fang Y; Zhang N
    Glycobiology; 2011 Aug; 21(8):1087-96. PubMed ID: 21470983
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recombinant glycoprotein production in human cell lines.
    Swiech K; de Freitas MC; Covas DT; Picanço-Castro V
    Methods Mol Biol; 2015; 1258():223-40. PubMed ID: 25447867
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region.
    Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
    J Biochem; 2006 Sep; 140(3):359-68. PubMed ID: 16861252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris.
    Choi BK; Warburton S; Lin H; Patel R; Boldogh I; Meehl M; d'Anjou M; Pon L; Stadheim TA; Sethuraman N
    Appl Microbiol Biotechnol; 2012 Aug; 95(3):671-82. PubMed ID: 22569635
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Formidable Challenge of Controlling High Mannose-Type N-Glycans in Therapeutic mAbs.
    Mastrangeli R; Audino MC; Palinsky W; Broly H; Bierau H
    Trends Biotechnol; 2020 Oct; 38(10):1154-1168. PubMed ID: 32616303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. FTIR spectroscopy as an analytical tool to compare glycosylation in therapeutic monoclonal antibodies.
    Derenne A; Derfoufi KM; Cowper B; Delporte C; Goormaghtigh E
    Anal Chim Acta; 2020 May; 1112():62-71. PubMed ID: 32334683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.